This Eucatech product is made with reduction in the neointimal hypeplasie thanks to the anti-proliferative drug setup in this product. This works for a drug content of 0.25µm/mm2 and releases it within eight to ten weeks after administered. This uses a degradable PLGA matrix with a low dose drug and works without creating inflammation. This uses a PLGA body to keep carbon dioxide and water in check. This is made with a Camouflage coating to keep the body protected and to make it all function without losing its energy as it is being used by a patient.
- Cardiovascular system : : coronary
- Characteristics: : drug eluting